Incruse Ellipta and Promacta

• Generic Name: umeclidinium
• Dosage Forms: aerosol, powder
• Other Brand Names: Incruse Ellipta

Incruse Ellipta (umeclidinium) is an anticholinergic that works by relaxing muscles in the airways to improve breathing.

Incruse Ellipta is used to prevent airflow obstruction and reduce flare-ups in adults with COPD (chronic obstructive pulmonary disease, including bronchitis and emphysema.

Incruse Ellipta is for use only in people with COPD and should not be used to treat asthma.

• Generic Name: eltrombopag
• Dosage Forms: tablet, film coated
• Other Brand Names: Promacta

Promacta (eltrombopag) is a man-made form of a protein that increases production of platelets (blood-clotting cells) in your body. Eltrombopag can lower the risk of bleeding by increasing platelets in your blood.

Promacta is used to prevent bleeding episodes in people with chronic immune thrombocytopenic purpura (ITP), a bleeding condition caused by a lack of platelets in the blood. This medicine is for use in adults and children who are at least 1 year old, after other medicines have been tried without success.

Promacta is also used to prevent bleeding in adults with chronic hepatitis C who are treated with an interferon (such as Intron A, Infergen, Pegasys, PegIntron, Rebetron, Redipen, or Sylatron).

Promacta is also used together with other medications to treat severe aplastic anemia in adults and children who are at least 2 years old.

Promacta is not a cure for ITP and it will not make your platelet counts normal if you have this condition.